Cara Therapeutics | CARA - Stock

Aktienkurs
3.93
Täglich Wechseln
-0.09 -2.24%
Monatlich
2.88%
Jährlich
-73.37%
Q1 Prognose
3.87




Stock Veränderung Datum
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Assertio Holdings USD 24.76M 8.12M 2025-09
Cara Therapeutics USD 900K 0 2025-03
Chugai Pharma JPY 246.33B 10.8B 2025-09
Cipla INR 61.6B 5.18B 2025-09
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
J&J USD 14.19B 45M 2025-12
Neurocrine Biosciences USD 69M 300K 2025-12
Pacira USD 152.86M 4.82M 2025-12
Pfizer USD 11.47B 201M 2025-09
RedHill Biopharma USD 3.17M 482K 2025-06
Supernus Pharmaceuticals USD 107.1M 63.08M 2025-09
Vanda Pharmaceuticals USD 1.85M 190K 2025-12